Robustness in cancer research refers to the ability of experimental results and clinical findings to remain consistent under various conditions. It is essential for ensuring that the outcomes of cancer studies are reproducible and can be generalized to a broader patient population. Robustness is crucial in the development of new treatments, as it ensures that therapies are effective across different demographics and genetic backgrounds.
